Verdad Advisers »

Myriad Genetics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $214k 38k 5.71

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Myriad Genetics

BlackRock
Millennium Management
Vestal Point Capital
D. E. Shaw & Co
State Street Corporation
Vanguard Capital Management
Morgan Stanley
Acadian Asset Management
Vanguard Portfolio Management
AQR Capital Management
Geode Capital Management
Goldman Sachs Group
Jacobs Levy Equity Management
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Myriad Genetics